Not available
Quote | Aptevo Therapeutics Inc. (NASDAQ:APVO)
Last: | $0.80 |
---|---|
Change Percent: | -1.73% |
Open: | $0.81 |
Close: | $0.80 |
High: | $0.82 |
Low: | $0.78 |
Volume: | 165,623 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
News | Aptevo Therapeutics Inc. (NASDAQ:APVO)
Lecture to focus on engineering strategies applied to design safe and efficacious bispecific drug candidates, utilizing our proprietary platform technologies SEATTLE, WA / ACCESSWIRE / May 14, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on ...
2024-05-08 11:25:32 ET More on Aptevo Therapeutics Seeking Alpha’s Quant Rating on Aptevo Therapeutics Historical earnings data for Aptevo Therapeutics Financial information for Aptevo Therapeutics Read the full article on Seeking Alpha For fur...
Message Board Posts | Aptevo Therapeutics Inc. (NASDAQ:APVO)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $APVO News Article - Aptevo Therapeutics Files Provisional Patent for Fifth Bispecific | whytestocks | investorshangout | 01/09/2023 7:35:48 PM |
It never does for those that hold.... ;-) | pinkslipjunkie | investorshub | 12/12/2022 11:32:28 PM |
znewcar1: $APVO 12% v39,4M c3.91 f5,091M H7.20 ML2.88 gapNcrap | znewcar1 | investorshangout | 12/12/2022 11:07:56 PM |
Almost a 1000 times normal volume and it's | ErnieBilco | investorshub | 12/12/2022 8:23:39 PM |
On December 12, 2022, Aptevo Therapeutics Inc. (Aptevo | ErnieBilco | investorshub | 12/12/2022 1:39:17 PM |
News, Short Squeeze, Breakout and More Instantly...
Aptevo Therapeutics Inc. Company Name:
APVO Stock Symbol:
NASDAQ Market:
Aptevo Therapeutics Inc. Website:
Lecture to focus on engineering strategies applied to design safe and efficacious bispecific drug candidates, utilizing our proprietary platform technologies SEATTLE, WA / ACCESSWIRE / May 14, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on ...
Heavily pre-treated breast cancer patient who achieved stable disease on study, remains on treatment for more than eleven months after entering the ALG.APV-527 Phase 1 trial with progressive disease and transitioning to higher dose with potential for greater clinical benefit, experienced no new a...
A look at the top 10 most actives in the United States Allarity Therapeutics Inc. (ALLR) rose 97.8% to $2.71 on volume of 44,141,232 shares Faraday Future Intelligent Electric Inc. (FFIE) fell 1.1% to $0.0456 on volume of 28,670,184 shares Emergent Biosolutions Inc. (EBS) rose 67.7% to $3...